Search - tctmd.com

Displaying 301 - 320 of 701

Sort: Relevancy | Date

News Conference News ISET 2018

Aortic Dissection: What’s Next in Endovascular Therapy

Caitlin E. Cox

February 06, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

Presentation ISET 2018

Best Techniques in 2018 for CAS Performance at Low Risk

Presenter: Chris Metzger

February 04, 2018

Presentation ISET 2018

Embolic Protection During CAS: Filters, Occlusion and Flow Reversals

Presenter: Claudio Schonholz

February 04, 2018

News Conference News ISC 2018

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

Todd Neale

January 30, 2018

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Caitlin E. Cox

January 11, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

First-in-Human Study of a Novel Transradial Device for Intra-aortic Embolic Deflection During TAVR Implantation

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Darren Mylotte

October 30, 2017

Presentation TCT 2017

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Daily News

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

Todd Neale

October 09, 2017

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

Advertisement

Aortic Dissection: What’s Next in Endovascular Therapy

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Best Techniques in 2018 for CAS Performance at Low Risk

Embolic Protection During CAS: Filters, Occlusion and Flow Reversals

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

First-in-Human Study of a Novel Transradial Device for Intra-aortic Embolic Deflection During TAVR Implantation

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

TCTMD’s Top 10 Most Popular Stories for October 2017

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content